Maddow notes for Trump, "Game over Big Guy, you lose"

557 Views | 4 Replies | Last: 27 days ago by Aunburdened
SBGold
How long do you want to ignore this user?
https://nypost.com/2025/06/10/media/rachel-maddow-declares-victory-against-trump-over-immigration-protests/

MAGAts, not ahead of the game and not smart enough to handle any real issues of note

VOTE BLUE

Go Bears Forever
PAC-10-BEAR
How long do you want to ignore this user?
Rachel Maddow, the pride and joy of Castro Valley!
dajo9
How long do you want to ignore this user?
The thing about the No Kings protest scaled against the failed military parade is that Congress sees the writing on the wall. 2026 is likely to be the end for lots of Republicans in the House. They know it even if they can't say it. So that puts pressure on anything Trump tries to do Congressionally.

Trump is on track to be a lame duck in November 2026. Maddow is expressing that she doesn't think he has what it takes to turn that around. Furthermore, if he can't get his tax cuts for the rich and health care cuts for the poor legislation passed, then he is already a lame duck. That means the GOP Congress has already abandoned Trump and they are looking out for themselves.
SBGold
How long do you want to ignore this user?
Hmm, I don't get what this means. I guess probably nothing of any significance.

VOTE BLUE

HATE MAGATs

Go Bears Forever
Aunburdened
How long do you want to ignore this user?
Quote:

With Russiagate fan fiction no longer tenable, Maddow now claims that Gulf states got him to bomb Iran. She gives only a passing mention to Israel, omitting that Israel lobbied for this bombing and directly participated it; and that Trump and his cabinet have deep ties to pro-Israel oligarchs. Trump has openly bragged that his Israel policies are shaped by Miriam and Sheldon Aldelson. That somehow has escaped the dogged eye of this leading member of Trump's media opposition.


Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.